Amneal Pharmaceuticals Statistics
NASDAQ: AMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
21.12-0.27 (-1.26%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Amneal Pharmaceuticals by the numbers
Amneal Pharmaceuticals has a market capitalization of $7.36 billion based on 348.41M shares outstanding. Its trailing P/E ratio is 52.8, above the 3-company peer median of 47.8, and its forward P/E is 17.1. The stock trades 4.9% above its 50-day average and 29.8% above its 200-day average.
Average daily trading volume is 3.16M shares, or about $66.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AMRX valuation vs. peer median
| Metric | AMRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.36B | $7.46B | -1% |
| P/E (TTM) | 52.8 | 47.8 | +10% |
| Forward P/E | 17.1 | 35.5 | -52% |
| Avg. volume | 3.16M | 1.18M | +168% |
Peer median across 8 companies: KNSA, ALKS, RYTM, CYTK, PTGX, CORT, SMMT, AXSM.
Valuation
- Market cap
- $7.36B
- P/E (TTM)
- 52.80
- Forward P/E
- 17.13
- Price / sales (latest FY)
- 2.44
- EPS (TTM)
- $0.40
- Shares outstanding
- 348.41M
Price and trading
- Previous close
- 21.39
- Open
- 21.25
- Day range
- 21.07 – 21.70
- 52-week range
- 11.71 – 22.13
- 52-week change
- +76.74%
- Beta
- —
- Volume
- 1.67M
- Average volume
- 3.16M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 7.36B
- Pe
- 52.80
- Forward Pe
- 17.13
- Eps
- 0.40
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 22.13
- Week52 Low
- 11.71
- Avg Volume
- 3.16M
- Shares Outstanding
- 348.41M
- Ma50
- 20.13
- Ma200
- 16.28
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -4.54%
- Pct From52w Low
- 80.36%